G
Ge Lin
Publications - 6
Citations - 18
Ge Lin is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 3, co-authored 6 publications receiving 18 citations.
Papers
More filters
Journal ArticleDOI
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Dimitrios Makrakis,Rafee Talukder,Ge Lin,Leonidas Diamantopoulos,Scott J. Dawsey,Shilpa Gupta,Lucia Carril-Ajuria,Daniel Castellano,I De Kouchkovsky,Vadim S. Koshkin,Joseph J. Park,Ajjai Alva,Mehmet Asim Bilen,Tyler F. Stewart,Rana R. McKay,Nishita Tripathi,Neeraj Agarwal,Naomi Vather-Wu,Yousef Zakharia,Rafael Morales-Barrera,Michael Edward Devitt,Alessio Cortellini,Fulgenzi Claudia Angela Maria,David J. Pinato,Ariel Ann Nelson,Christopher J. Hoimes,Kavita Gupta,Benjamin A. Gartrell,Alexander Sankin,Abhishek Tripathi,Roubini Zakopoulou,Aristotelis Bamias,Jure Murgic,Ana Fröbe,Alejo Rodriguez-Vida,Alexandra Drakaki,Sandy T. Liu,Eric Wun-Hao Lu,Vivek Kumar,Giuseppe Di Lorenzo,Monika Joshi,Pedro Isaacsson-Velho,Lucia Alonso Buznego,Ignacio Duran,Marcus Marie Moses,Albert Jang,Pedro C. Barata,Guru Sonpavde,Evan Y. Yu,R. Bruce Montgomery,Petros Grivas,Ali Raza Khaki +51 more
TL;DR: In this article , the authors found that the presence of liver/bone metastases would be associated with worse outcomes with immune checkpoint inhibitors (ICI) in urothelial carcinoma (aUC).
Journal ArticleDOI
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Dimitrios Makrakis,Dimitra Rafailia Bakaloudi,Rafee Talukder,Ge Lin,Leonidas Diamantopoulos,T. Jindal,Naomi Vather-Wu,Yousef Zakharia,Nishita Tripathi,Neeraj Agarwal,Scott J. Dawsey,Shilpa Gupta,Eric Wun-Hao Lu,Alexandra Drakaki,Sandy T. Liu,Roubini Zakopoulou,Aristotelis Bamias,Claudia Angela Maria Fulgenzi,Alessio Cortellini,David J. Pinato,Pedro C. Barata,Petros Grivas,Ali Raza Khaki,Vadim S. Koshki +23 more
TL;DR: In this paper , the authors examined patient and disease characteristics, toxicity, and clinical outcomes for patients with advanced urothelial carcinoma (aUC) who are rechallenged with immune checkpoint inhibitor (ICI)-based therapy.
Journal ArticleDOI
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Rafee Talukder,Dimitrios Makrakis,Ge Lin,Leonidas Diamantopoulos,Scott J. Dawsey,Shilpa Gupta,Lucia Carril-Ajuria,Daniel Castellano,I De Kouchkovsky,T. Jindal,Vadim S. Koshkin,Joseph J. Park,Ajjai Alva,Mehmet Asim Bilen,Tyler F. Stewart,Rana R. McKay,Nishita Tripathi,Neeraj Agarwal,Naomi Vather-Wu,Yousef Zakharia,Rafael Morales-Barrera,Michael Edward Devitt,Alessio Cortellini,Fulgenzi Claudia Angela Maria,David J. Pinato,Ariel Ann Nelson,Christopher J. Hoimes,Kavita Gupta,Benjamin A. Gartrell,Alexander Sankin,Abhishek Tripathi,Roubini Zakopoulou,Aristotelis Bamias,Jure Murgic,Ana Fröbe,Alejo Rodriguez-Vida,Alexandra Drakaki,Sandy T. Liu,Eric Wun-Hao Lu,Vivek Kumar,Giuseppe Di Lorenzo,Monika Joshi,Pedro Isaacsson-Velho,Lucia Alonso Buznego,Ignacio Duran,M. Ms,Pedro C. Barata,Guru Sonpavde,Jonathan L. Wright,Evan Y. Yu,R. Bruce Montgomery,Andrew C. Hsieh,Petros Grivas,Ali Raza Khaki +53 more
TL;DR: In this article , the authors performed a retrospective multi-institution cohort study in patients with advanced urothelial carcinoma (aUC) treated with 1L platinum-based chemotherapy, who received 2L ICI.
Journal ArticleDOI
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Dimitra Rafailia Bakaloudi,Rafee Talukder,Ge Lin,Dimitrios Makrakis,Leonidas Diamantopoulos,Nishita Tripathi,Neeraj Agarwal,Roubini Zakopoulou,Aristotelis Bamias,Jason Brown,David J. Pinato,J. Korolewicz,T. Jindal,Vadim S. Koshkin,Jure Murgic,Marija Miletić,A. Frobe,Jeffrey Johnson,Yousef Zakharia,Alexandra Drakaki,Alejo Rodriguez-Vida,M. Rey-Cárdenas,Daniel Castellano,Lucia Alonso Buznego,Ignacio Duran,R. Morales Barrera,Rana R. McKay,Tyler F. Stewart,Shilpa Gupta,Andrew Ruplin,Evan Y. Yu,Ali Raza Khaki,Petros Grivas +32 more
TL;DR: In this paper , the authors describe clinical features and outcomes in a "real-world" cohort treated with avelumab maintenance for urothelial carcinoma (aUC).
Journal ArticleDOI
Abstract 1981: Immune related liver toxicity and potential risk factors: A case-control study
Eric Storm,Dimitrios Makraki,Ge Lin,Laura C. Kennedy,Eshana E. Shah,Amanda I. Phipps,Iris Liou,David M. Hockenbery,Petros Grivas,Ali Raza Khaki +9 more
TL;DR: An independent negative association between liver cirrhosis and irH is demonstrated, while liver metastasis was not significantly associated with increased odds of irH after adjustment for covariates.